Breast Cancer Theranostics
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Medical Imaging and Theranostics".
Deadline for manuscript submissions: closed (16 December 2022) | Viewed by 31391
Special Issue Editors
Interests: thyroid; thyroid cancer; surgery
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Breast cancer is the most common invasive cancer in the world and the second leading cause of cancer deaths in females. The survival rate of breast cancer patients has improved due to the increase in screening programs and the emergence of novel drugs. However, the survival outcomes in metastatic breast cancer are still poor. The heterogeneity of breast cancer poses a challenge to its management. Various factors affect the prognosis, aggressive phenotype, and treatment response of breast cancer.
A major challenge in the management of breast cancer is individual variability among patients. Recently, increased understanding of breast cancer biology had led to the identification of specific targets, expressed on cancer cells, that can be used for diagnosis and therapy at the molecular level of a specific individual, thus improving the therapeutic outcome. Theranostics is the combination of the diagnostic and therapeutic agents targeted at the same biomarker such as HER2. The advantage of the theranostic approach is that it identifies individuals who would benefit from a specific treatment and, thus, prevent the implementation of potentially futile treatments. This Special Issue of Diagnostics aims to provide an overview of the current developments in theranostics for breast cancer.
Dr. Kwangsoo Kim
Dr. Chang Ik Yoon
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.